Cargando…

Response to Lenvatinib Is Associated with Optimal RelativeDose Intensity in Hepatocellular Carcinoma: Experience in Clinical Settings

Background: Lenvatinib is currently available as the first-line treatment for advanced unresectable hepatocellular carcinoma. We evaluated the relationship between its relative dose intensity (RDI) and response in clinical settings. Methods: From March 2018 to May 2019, 93 patients were administered...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sasaki, Ryu, Fukushima, Masanori, Haraguchi, Masafumi, Miuma, Satoshi, Miyaaki, Hisamitsu, Hidaka, Masaaki, Eguchi, Susumu, Matsuo, Satoshi, Tajima, Kazuaki, Matsuzaki, Toshihisa, Hashimoto, Satsuki, Ooba, Kazuo, Kugiyama, Yuki, Yatsuhashi, Hiroshi, Motoyoshi, Yasuhide, Shigeno, Masaya, Kinoshita, Noboru, Nakao, Kazuhiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895891/ https://www.ncbi.nlm.nih.gov/pubmed/31717674 http://dx.doi.org/10.3390/cancers11111769

Ejemplares similares

Evaluating the Role of Hepatobiliary Phase of Gadoxetic Acid-Enhanced Magnetic Resonance Imaging in Predicting Treatment Impact of Lenvatinib and Atezolizumab plus Bevacizumab on Unresectable Hepatocellular Carcinoma
por: Sasaki, Ryu, et al.
Publicado: (2022)

Shunt occlusion prior to lenvatinib administration prevents hepatic encephalopathy and hyperammonemia
por: Kuwahara, Ai, et al.
Publicado: (2020)

Impact of lenvatinib on renal function compared to sorafenib for unresectable hepatocellular carcinoma
por: Sasaki, Ryu, et al.
Publicado: (2022)

Most Cases of Cryptogenic Cirrhosis May Be Nonobese Nonalcoholic Steatohepatitis - Risk Factors of Liver Steatosis After Liver Transplantation for Cryptogenic Cirrhosis: A Retrospective Study
por: Fukushima, Masanori, et al.
Publicado: (2022)

The impact of single-nucleotide polymorphisms on liver stiffness and controlled attenuation parameter in patients treated with direct-acting antiviral drugs for hepatitis C infection
por: Matsumoto, Kosuke, et al.
Publicado: (2022)

Hypoglycemia measured by flash glucose monitoring system predicts liver-related events in chronic liver disease patients
por: Sasaki, Ryu, et al.
Publicado: (2023)

Comparative study of the effect of neuromuscular electrical stimulation and oral administration of branched-chain amino acid on preventing sarcopenia in patients after living-donor liver transplantation: study protocol for an open-label randomized controlled trial
por: Haraguchi, Masafumi, et al.
Publicado: (2021)

The Long-term Efficacy of Sodium Glucose Co-transporter 2 Inhibitor in Patients with Non-alcoholic Fatty Liver Disease
por: Yamashima, Mio, et al.
Publicado: (2019)

Inferior Vena Cava Anomalies with Portal Vein System Continuation Presenting as Portal Hypertension with a Long-term Follow-up
por: Fukushima, Masanori, et al.
Publicado: (2020)

Fully covered metallic stents for anastomotic biliary strictures after living donor liver transplantation
por: Komatsu, Naohiro, et al.
Publicado: (2023)

Blood carnitine profiling on tandem mass spectrometry in liver cirrhotic patients
por: Miyaaki, Hisamitsu, et al.
Publicado: (2020)

Intractable Hepatic Encephalopathy with a Large Portosystemic Shunt Successfully Treated Using Shunt-preserving Disconnection of the Portal and Systemic Circulation
por: Haraguchi, Masafumi, et al.
Publicado: (2020)

Peripheral lymphocyte fluctuation as an indicator of severe immune‐related adverse events in patients treated with immune checkpoint inhibitors
por: Haraguchi, Masafumi, et al.
Publicado: (2023)

Comparison of the novel Franseen needle versus the fine‐needle aspiration needle in endoscopic ultrasound‐guided tissue acquisition for cancer gene panel testing: A propensity score‐matching analysis
por: Mori, Tomotaka, et al.
Publicado: (2023)

Prediction of Liver Prognosis from Pre-Transplant Renal Function Adjusted by Diuretics and Urinary Abnormalities in Adult-to-Adult Living Donor Liver Transplantation
por: Kitamura, Mineaki, et al.
Publicado: (2020)

Influence of Interferon-free Direct-acting Antiviral Therapy on Primary Hepatocellular Carcinoma Recurrence: A Landmark Time Analysis and Time-dependent Extended Cox Proportional Hazards Model Analysis
por: Miuma, Satoshi, et al.
Publicado: (2020)

The Kupffer Cell Number Affects the Outcome of Living Donor Liver Transplantation from Elderly Donors
por: Hidaka, Masaaki, et al.
Publicado: (2016)

Elevated Fasting Plasma Glucose before Liver Transplantation is Associated with Lower Post-Transplant Survival
por: Katsura, Emi, et al.
Publicado: (2016)

Association Between Trough Level of Tacrolimus and Change in Estimated Glomerular Filtration Rate 1 Year After Living Donor Liver Transplantation
por: Muta, Kumiko, et al.
Publicado: (2021)

Treatment of Hepatitis C Virus Infection with Direct-acting Antiviral Agents Elevates the Serum Small-dense Low-density Lipoprotein Cholesterol Level
por: Hino, Naoyuki, et al.
Publicado: (2021)

Evolution of Liver Transplantation Over the Last 2 Decades Based on a Single-Center Experience of 300 Cases
por: Soyama, Akihiko, et al.
Publicado: (2023)

Carotid Intima-media Thickness and Small Dense Low-density Lipoprotein Cholesterol Increase after One Year of Treatment with Direct-acting Antivirals in Patients with Hepatitis C Virus Infection
por: Ichikawa, Tatsuki, et al.
Publicado: (2019)

Initial and advanced endoscopic findings of monomorphic epitheliotropic intestinal T‐cell lymphoma in the duodenum: A case report
por: Fukushima, Masanori, et al.
Publicado: (2022)

Extracellular vesicles from senescent hepatic stellate cells promote cell viability of hepatoma cells through increasing EGF secretion from differentiated THP-1 cells
por: Miyazoe, Yuri, et al.
Publicado: (2020)

Geranylgeranylacetone attenuates fibrogenic activity and induces apoptosis in cultured human hepatic stellate cells and reduces liver fibrosis in carbon tetrachloride-treated mice
por: Senoo, Takemasa, et al.
Publicado: (2018)

Direct-acting Antivirals Improved the Quality of Life, Ameliorated Disease-related Symptoms, and Augmented Muscle Volume Three Years Later in Patients with Hepatitis C Virus
por: Ichikawa, Tatsuki, et al.
Publicado: (2020)

Comparison of calculated body muscle mass and SARC-F as methods of screening for sarcopenia in patients with chronic liver disease
por: Ichikawa, Tatsuki, et al.
Publicado: (2021)

Change in tartrate-resistant acid phosphatase isoform 5b levels, a marker of bone metabolism, in patients with chronic hepatitis B treated with tenofovir alafenamide
por: Okamura, Takuma, et al.
Publicado: (2022)

Living donor liver transplantation from a donor previously treated with interferon for hepatitis C virus: a case report
por: Hidaka, Masaaki, et al.
Publicado: (2011)

Hepatitis C Virus Infection Increases c-Jun N-Terminal Kinase (JNK) Phosphorylation and Accentuates Hepatocyte Lipoapoptosis
por: Takaki, Hiroko, et al.
Publicado: (2017)

Long‐term outcomes of living‐donor liver transplantation, hepatic resection, and local therapy for hepatocellular carcinoma with three <3‐cm nodules in a single institute
por: Hidaka, Masaaki, et al.
Publicado: (2022)

Comparison of Histological Sample Volumes among Various Endoscopic Ultrasound-Guided Biopsy Needles
por: Takahashi, Kosuke, et al.
Publicado: (2021)

Intrahepatic MicroRNA Profile of Liver Transplant Recipients with Hepatitis C Virus Co-Infected with Human Immunodeficiency Virus
por: Miyaaki, Hisamitsu, et al.
Publicado: (2017)

Frequency of elevated biomarkers in patients with cryptogenic hepatocellular carcinoma
por: Taura, Naota, et al.
Publicado: (2013)

Baseline Serum Cholesterol Is Associated with a Response to Pegylated Interferon Alfa-2b and Ribavirin Therapy for Chronic Hepatitis C Genotype 2
por: Taura, Naota, et al.
Publicado: (2012)

A prospective observational cohort study of lenvatinib as initial treatment in patients with BCLC-defined stage B hepatocellular carcinoma
por: Kobayashi, Satoshi, et al.
Publicado: (2022)

Therapeutic efficacy of lenvatinib for patients with unresectable hepatocellular carcinoma based on the middle-term outcome
por: Fuchigami, Akira, et al.
Publicado: (2020)

Two difficulty diagnosis cases of severe veno-occlusive disease
por: Miyaaki, Hisamitsu, et al.
Publicado: (2013)

A Case of Squamous Cell Carcinoma of Unknown Primary that Responded to the Multi-Tyrosine Kinase Inhibitor Lenvatinib
por: Kimura-Tsuchiya, Reiko, et al.
Publicado: (2018)

High serum concentrations of growth differentiation factor-15 and their association with Crohn’s disease and a low skeletal muscle index
por: Yamamoto, Hiroyuki, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_abkknijv5oej39f53u2eorn4oq